The Wilms tumor suppressor WT1 directs stage-specific quiescence and differentiation of human hematopoietic progenitor cells.
about
Regulation of mTOR and cell growth in response to energy stress by REDD1.Wilms tumor 1 mutations in the pathogenesis of acute myeloid leukemiaSignificance of oncogenes and tumor suppressor genes in AML prognosis.Staf50 is a novel p53 target gene conferring reduced clonogenic growth of leukemic U-937 cells.Hematopoietic stem cells and retroviral infection.Prognostic implications of mutations and expression of the Wilms tumor 1 (WT1) gene in adult acute T-lymphoblastic leukemia.Adoptive transfer of unselected or leukemia-reactive T-cells in the treatment of relapse following allogeneic hematopoietic cell transplantation.Podocalyxin in human haematopoietic cells.Cell cycle regulators and hematopoiesis.Genetic profile of acute myeloid leukemia.Wilms' tumours: about tumour suppressor genes, an oncogene and a chameleon gene.WT1 in acute leukemia, chronic myelogenous leukemia and myelodysplastic syndrome: therapeutic potential of WT1 targeted therapies.Hypoxia-sensitive epigenetic regulation of an antisense-oriented lncRNA controls WT1 expression in myeloid leukemia cellsThe Wilms' tumour suppressor protein WT1 acts as a key transcriptional repressor of the human thromboxane A2 receptor gene in megakaryocytes.Exploiting T cell receptor genes for cancer immunotherapy.Mapping of novel peptides of WT-1 and presenting HLA alleles that induce epitope-specific HLA-restricted T cells with cytotoxic activity against WT-1(+) leukemias.Wilms' tumour: connecting tumorigenesis and organ development in the kidney.Mutations in the neutral sphingomyelinase gene SMPD3 implicate the ceramide pathway in human leukemias.Central role of PI3K in transcriptional activation of hTERT in HTLV-I-infected cellsImmunosuppression for myelodysplastic syndrome: how bench to bedside to bench research led to successCharacterization of the expression of HTm4 (MS4A3), a cell cycle regulator, in human peripheral blood cells and normal and malignant tissuesInteractive diagnostics in the indication to allogeneic SCT in AML.WT1 vaccination in acute myeloid leukemia: new methods of implementing adoptive immunotherapy.An isoform of the Wilms' tumor suppressor gene potentiates granulocytic differentiation.The Role of WT1 in Embryonic Development and Normal Organ Homeostasis.Mimicking Muscle Stem Cell Quiescence in Culture: Methods for Synchronization in Reversible Arrest.Prognostic impact of Wilms tumor gene mutations in Egyptian patients with acute myeloid leukemia with normal karyotype.Enhancement of lytic activity of leukemic cells by CD8+ cytotoxic T lymphocytes generated against a WT1 peptide analogue.WT1 induction of mitogen-activated protein kinase phosphatase 3 represents a novel mechanism of growth suppression.WT1 expression in angiogenic tumours of the skin.Ikaros induces quiescence and T-cell differentiation in a leukemia cell line.Transcriptional activation of c-myc proto-oncogene by WT1 protein.Monocyte differentiation to macrophage requires interferon regulatory factor 7.Gene Expression Differences between Enriched Normal and Chronic Myelogenous Leukemia Quiescent Stem/Progenitor Cells and Correlations with Biological Abnormalities.Studies of Wilms' Tumor (WT1) Gene Expression in Adult Acute Leukemias in SingaporeAbnormal WT1 expression in the CD34-negative compartment in myelodysplastic bone marrow.A rare but specific subset of adult AML patients can be defined by the cytogenetically cryptic NUP98-NSD1 fusion gene.Multiplex real-time RT-PCR for prospective evaluation of WT1 and fusion gene transcripts in newly diagnosed de novo acute myeloid leukemia.Acute myeloid leukemia bearing t(7;11)(p15;p15) is a distinct cytogenetic entity with poor outcome and a distinct mutation profile: comparative analysis of 493 adult patients.Will changing the face of WT1 make it more attractive to T cells?
P2860
Q24531971-583FBA31-A4AD-4FC6-8FB3-EC249322C06CQ26744111-6F60F592-6317-4556-9855-855FDFAC7A0EQ30250315-E1EEE593-FBAD-458E-92E3-E2E27171CE5EQ33200966-91F450FD-B04A-4C37-8345-FCC420354036Q33677922-D32288B7-28F5-4F24-A3F5-17317DCFACBFQ33886181-627C0AA8-D9FD-4AB6-A7B5-D4A9E36C9B98Q34279672-8DFA0836-A86D-4006-80D3-1D03C8DDA6EAQ34304070-7E2E0DED-CD9A-4060-B946-07894B388B15Q34658558-257F704E-9889-4158-B67E-AEC397A5248BQ34680927-475511EB-0CE5-4912-AD78-E1EB0979C8A0Q35095712-A1DBA81C-5841-4142-B3FE-79E50E696C5AQ35166856-C427C768-CBBB-4A82-A479-9CAFFDD3D2E3Q35203507-E1B1CD41-BCC4-4A9A-96CF-7AA529BBAB5AQ35889126-5E2FF574-66CE-4A75-9314-BE7CFE65FB3FQ36011784-7FE2D75F-BAD8-4A11-9B54-15B29FBF4837Q36194241-A4CE66BA-758D-4A30-A9DF-A91171C34452Q36234726-AB713559-EAFD-42BA-9093-3CC6D191BA92Q36591365-F9B90F35-41BA-4476-BE8E-ED585DE9DABCQ36915936-88BD7AD1-CC95-47F9-8064-90F25F2A02B9Q37222206-92551150-4DF0-4975-B299-D4EED618E4E0Q37293778-447AB78C-9B6C-44F3-88C6-6443968D56DAQ37442649-869B03E8-825A-44DB-BD19-40745C611AAFQ38187457-34F4D2AF-12C3-4756-932E-EDBA32F5209CQ38354567-8CF47995-DD9B-4261-A21E-342E6DF17DD6Q38897318-AF91E512-A7EF-4354-8FAA-96FDA855BB64Q39155803-F23C4C77-64A4-4D48-8070-E92FDD5A5902Q39631733-5734B108-B234-4BAF-B0FB-6B0B05437129Q39886839-489C6CD3-6D10-4C70-9C90-6A0D44ED34E4Q39958704-150F4CD4-0E3F-4088-A712-2FF898940CE7Q40404352-95B25731-A096-440A-A33B-2AE767165ED3Q40457915-39BA063B-246C-4C11-B728-B6C9A2FEBC0AQ40529835-18844FBA-4F7C-463D-AAA7-AE1A650582D3Q40776864-BE5C1CFB-7AE6-4133-BB6E-516FF2A51EAEQ41891308-EF7AC329-6D68-46E1-8C8F-E6317F94C89BQ42617564-93A91F3F-2C73-41E7-B037-AB8DD772B6C6Q44117292-41FC6D45-EBC5-485E-B310-C0B2058C5FE6Q45378151-98F1B444-CA1E-4B96-8F1E-B03B2C0084D8Q47273221-A8A9F2B1-2EDE-4DF6-A952-E0EDDF82ED2FQ51655820-E5575BBA-EF84-44A5-873E-BED4A127383AQ51806477-1D49C369-9ADF-4751-9E2D-0BC6B335483C
P2860
The Wilms tumor suppressor WT1 directs stage-specific quiescence and differentiation of human hematopoietic progenitor cells.
description
2001 nî lūn-bûn
@nan
2001 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
The Wilms tumor suppressor WT1 ...... ematopoietic progenitor cells.
@ast
The Wilms tumor suppressor WT1 ...... ematopoietic progenitor cells.
@en
The Wilms tumor suppressor WT1 ...... ematopoietic progenitor cells.
@nl
type
label
The Wilms tumor suppressor WT1 ...... ematopoietic progenitor cells.
@ast
The Wilms tumor suppressor WT1 ...... ematopoietic progenitor cells.
@en
The Wilms tumor suppressor WT1 ...... ematopoietic progenitor cells.
@nl
prefLabel
The Wilms tumor suppressor WT1 ...... ematopoietic progenitor cells.
@ast
The Wilms tumor suppressor WT1 ...... ematopoietic progenitor cells.
@en
The Wilms tumor suppressor WT1 ...... ematopoietic progenitor cells.
@nl
P2093
P2860
P356
P1433
P1476
The Wilms tumor suppressor WT1 ...... ematopoietic progenitor cells.
@en
P2093
P2860
P304
P356
10.1093/EMBOJ/20.8.1897
P407
P577
2001-04-01T00:00:00Z